She had been in anxiety treatment for three years. CBT, two different SSRIs, mindfulness-based approaches. She had worked hard and the treatment had helped, partially. But something wasn't resolving. The panic attacks continued arriving without clear triggers. Her body felt unstable in a way she couldn't account for through psychological work alone.
She was 46. Nobody had asked about perimenopause.
This presentation is common. Perimenopausal symptoms are often mistaken, in my experience, for a primary anxiety disorder. I have not been able to find a reliable figure for how often this happens, which is itself part of the problem. The confusion is clinically understandable - but its consequences matter. Years of treatment oriented toward the wrong primary driver produce partial relief at best and, over time, a familiar demoralisation: the belief that the problem is simply more intractable than it should be.
Why the confusion is understandable
Hot flushes and panic attacks can overlap a great deal. Both can involve rapid heartbeat, sweating or flushing, difficulty breathing, chest tightness, a sense of losing control, and a feeling of impending doom. For a woman experiencing these symptoms - and for a clinician assessing them without specific perimenopause training - distinguishing between a vasomotor symptom and a panic attack is difficult.
The confusion is compounded by the fact that anxiety symptoms in perimenopausal women are less researched than depressive symptoms. Most research into perimenopausal mood has focused on depression. Anxiety is common during this transition, well-documented in clinical experience, but the evidence base for distinguishing perimenopausal anxiety from primary anxiety disorder is thinner than it should be.
The critical difference: mechanism informs treatment
Despite the overlapping presentation, the mechanisms are distinct - and mechanism informs what treatment is appropriate.
Panic attacks can be set off by thoughts, situations or bodily sensations, and they can also come out of nowhere - unexpected attacks are the defining feature of panic disorder, so a lack of clear triggers does not by itself point to hormones. Panic attacks are accompanied by catastrophic cognitive content - thoughts about dying, losing control, or going mad. They respond to cognitive and psychological intervention: thought challenging, behavioural experiments, exposure, grounding techniques. Anxiety-specific medications - SSRIs, SNRIs, benzodiazepines - provide relief, and some of the same antidepressants are also used to treat hot flushes, so the treatments do not split neatly along these lines.
Vasomotor symptoms come from hormonal fluctuation affecting the hypothalamus, the brain's temperature regulation system. They arrive regardless of thought content. A woman can be in a calm, familiar environment with no psychological stressor present and experience a wave of heat, racing heart, and chest tightness. CBT cannot switch off the hormonal trigger. But in a randomised trial in the UK (Ayers and colleagues, Menopause, 2012), group and self-help CBT made hot flushes and night sweats less of a problem for women and reduced how often the night sweats came, and the benefit was still there six months later.
Treatment for anxiety that doesn't address the hormonal biology providing the substrate for symptoms may provide only incomplete relief. Which is exactly what many women describe: the anxiety work is helpful, but something keeps returning that the psychological treatment alone cannot fully reach.
When perimenopause provokes genuine anxiety
The picture is complicated further by the fact that perimenopause can also provoke anxiety that was not there before. Anxiety in these years is not imagined, and it is not only a matter of what is happening in a woman's life.
The evidence points to sensitivity rather than to a switch being flipped. Hormonal variability appears to raise how strongly the body reacts to stress rather than to generate distress on its own. In one study, the women whose oestradiol swung most widely reported more depressive symptoms, but only among those also carrying a higher load of very stressful life events. That matches what women describe. The same week that would have been manageable two years ago now leaves them shaky, and nothing about the week has changed.
In clinical practice, both are often true simultaneously. There may be an underlying anxiety vulnerability that predates perimenopause. A neurobiological amplifier also arrives with the transition. Treating only the psychological component, or only the hormonal component, leaves the other layer unaddressed.
What adequate assessment involves
Adequate assessment of new-onset anxiety in a woman in her forties or early fifties includes the hormonal context as a routine part of the clinical picture. It means ensuring that the question is asked, that menstrual pattern changes are noted, that vasomotor symptoms are actively assessed, and that the timing of symptom onset is considered in relation to the perimenopausal window.
It also means holding both the psychological and the neurobiological dimensions without collapsing one into the other. A woman with a prior history of anxiety who is now in perimenopause may need both psychological support for the anxiety patterns she has carried for years, and hormonal stabilisation that may reduce the neurobiological amplification of those patterns. These are complementary treatments.
What to ask if standard treatment isn't working
For women in their forties who are receiving anxiety treatment that is providing only partial relief - especially if the panic attacks have come together with night sweats or changes in the menstrual cycle, or if there is a pattern of temperature dysregulation accompanying the anxiety - it makes sense to ask directly whether the hormonal context has been assessed.
The anxiety is real. The question is what is driving it, and whether the full picture is being treated.
Hormonal stabilisation during perimenopause - where clinically appropriate and after assessment of individual history and risk - has some evidence behind it for low mood during the transition, especially when hot flushes are part of the picture. For anxiety the evidence is still early: one small trial (Lozza-Fiacco and colleagues, Psychoneuroendocrinology, 2022) found that an oestradiol patch reduced anxiety in perimenopausal women compared with a placebo patch. It is not the right choice for everyone. But it is a clinical option that deserves to be on the table, not discovered years later after exhaustive work in the wrong direction.
The women I see who have arrived at this understanding after several years of incomplete treatment are not angry at their previous clinicians. They are, more often, tired. Tired of a problem that was never correctly named, and relieved - visibly, sometimes for the first time in years - when it finally is.
If you want to name what is happening for you right now, take the free Midlife Quiz.
If this speaks to you, subscribe to my mailing list.
Subscribe